User Safety and Informed Consent
Information provided to potential participants must be transparent and accurate. This includes clear disclosure of potential risks, study objectives, and the experimental nature of the trial. Content should not exploit users' vulnerabilities or use deceptive tactics to encourage participation. All communications must facilitate informed decision-making without applying undue pressure.
Data Privacy and Protection
When collecting personal information from individuals interested in clinical trials, strict adherence to data privacy regulations is mandatory. If location data or device information is gathered, users must be notified of how their data will be used, including any sharing with partners. Explicit consent must be obtained prior to data collection, and all data transmissions should be secured through encryption.
Prohibited Content and Practices
Content must not involve harassment, intimidation, or bullying of individuals or groups. It should avoid promoting self-harm or violence. Additionally, any form of misinformation related to health crises or scientific consensus is strictly prohibited. This includes denials of recognized medical conditions or promotion of harmful health practices.
Advertising Standards
Advertisements for facial filler trials must not use misleading experiences or deceptive interfaces. They should comply with established quality ad standards, avoiding intrusive formats such as pop-ups or auto-playing videos with sound. All promotional content must be clear, honest, and not exaggerate potential outcomes.
Geographic and Legal Restrictions
Note that advertisers and publishers from certain sanctioned regions are prohibited from using related advertising services. Content must not target individuals in violation of export controls or sanctions enforced by relevant authorities.
Adherence to these guidelines ensures that information about facial filler trials is communicated responsibly, prioritizing user safety and regulatory compliance.